Updated Oct 2, 2015 04:04 PM ET
Prior Close: $47.55
Zacks Rank : 3-Hold [?] 3
Style Scores [?] : Growth: B | Value: B | Momentum: B
The Zacks Scorecard is a complimentary set of indicators to use alongside the Zacks Rank. It allows the investor to better focus on the stocks that are the best fit for his or her personal investment style.
We produce five unique ratings, including the Zacks Style Score, which combines the individual style scores into 1 rating:
|Zacks Style Score||A|
Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.
As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a score of an A or a B in your personal trading style.
Zacks Scorecard Education - Learn more about the Zacks Scorecard
The three scores are based on the trading styles of Growth, Value, and Momentum.
As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.
Zacks Style Scores Education - Learn more about the Zacks Style Scores
|Zacks Rank||Definition||Annualized Return|
Zacks Rank Education - Learn about the Zacks Rank
Zacks Rank Home - Zacks Rank resources in one place
Zacks Premium - The way to access to the Zacks Rank
Sanofi-Aventis is a global pharmaceutical company that contributes to enhance life by providing medicines, vaccines, and integrated healthcare solutions adapted to local needs and means primarily in Europe and the United States. The company is engaged in the research, development, manufacture and marketing of healthcare products. Its strategy is built around three priorities to reach its goals and ensure sustainable growth. The priorities are: increasing innovation in Research and Development, adapting Group structures to future challenges and seizing external growth opportunities. Sanofi-Aventis specializes in six therapeutic areas: thrombosis, cardiovascular, metabolic disorders, oncology, central nervous system (CNS) and internal medicine. The Company offers vaccines in five areas: pediatric combination vaccines, influenza vaccines, adult and adolescent booster vaccines, meningitis vaccines, and travel and endemic vaccines. Sanofi-Aventis is headquartered in Paris, France.
54 RUE LA BOETIE
PARIS, I0 75008
|Industry||LARGE CAP PHARMA|
|Fiscal Year End||December|
|Last Reported Quarter||6/30/2015|
|Next EPS Date||10/27/2015|
|Current Quarter EPS Consensus Estimate||0.90|
|Current Year EPS Consensus Estimate||3.16|
|Estimated Long-Term EPS Growth Rate||7.80|
|Next EPS Report Date||10/27/2015|
Price and Volume Information
|52 Week High||55.03|
|52 Week Low||43.57|
|20 Day Moving Average||984,317.88|
|Target Price Consensus||63.70|
|Shares Outstanding (millions)||2,622.05|
|Market Capitalization (millions)||126,566.27|
|Last Split Date||NA|
|Change in Payout Ratio||-0.01|
|Last Dividend Payout / Amount||NA / $0.00|
|Trailing 12 Months||14.90|
|vs. Previous Year||8.33%|
|vs. Previous Quarter||6.85%|
|vs. Previous Year||-4.10%|
|vs. Previous Quarter||6.08%|
|Price / Sales||3.04|